Development of REDX05358, a novel highly selective and potent pan RAF inhibitor and a potential therapeutic for BRAF and RAS mutant tumors


Mason H., Scrace S., Testar R., Rainard J., Talab F., Poonawala R., ...More

Annual Meeting of the American-Association-for-Cancer-Research (AACR), Washington, Kiribati, 1 - 05 April 2017, vol.77 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 77
  • Doi Number: 10.1158/1538-7445.am2017-5160
  • City: Washington
  • Country: Kiribati
  • Erciyes University Affiliated: No